A pontine stroke happens when blood flow to the pons in the brainstem is blocked or bursts. Early signs of a pontine stroke can include dizziness, weakness, and slurred speech Getting treatment, such ...

Intravenous thrombolysis (IVT) administered within 4.5 hours was linked to significantly lower risk for neurological deterioration in acute pontine infarction than other antithrombotic therapies, new ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Helius Medical Technologies, Inc. announced positive outcomes from its Portable Neuromodulation Stimulator (PoNS) Stroke Registrational Program (SRP), which supports a planned FDA submission for ...

VALENCIA, Calif., June 29, 2026 /PRNewswire/ -- Bioness Medical, Inc. ("Bioness", or the "Company"), a global leader in functional electrical stimulation (FES) and advanced rehabilitation technologies ...

NEWTOWN, Pa., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), today announced the filing of its U.S. Food and Drug Administration (FDA) 510(k) submission for the ...

DEAR DR. DONOHUE: A few months ago, my husband passed away. He had been in reasonably good health, took care of himself, ate sensibly, watched his weight and exercised religiously. He had an irregular ...

NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and ...

The PoNS has not yet been approved in the United States for use in stroke rehabilitation and remains investigational for this use. Helius is planning to file a submission to the FDA for an indication ...